A detailed history of Td Private Client Wealth LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 70,723 shares of ABBV stock, worth $13.8 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
70,723
Holding current value
$13.8 Million
% of portfolio
0.38%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $10.9 Million - $12.8 Million
70,723 New
70,723 $12.1 Billion
Q1 2024

Aug 16, 2024

SELL
$159.82 - $182.1 $1.32 Million - $1.5 Million
-8,259 Reduced 11.28%
64,965 $11.8 Billion
Q4 2023

Aug 16, 2024

SELL
$137.6 - $154.97 $378,262 - $426,012
-2,749 Reduced 3.62%
73,224 $11.4 Billion
Q3 2023

Aug 16, 2024

BUY
$133.59 - $154.65 $41,813 - $48,405
313 Added 0.41%
75,973 $11.3 Billion
Q2 2023

Aug 16, 2024

SELL
$132.51 - $164.9 $2.22 Million - $2.76 Million
-16,734 Reduced 18.11%
75,660 $10.2 Billion
Q1 2023

Aug 16, 2024

SELL
$144.61 - $166.54 $203,900 - $234,821
-1,410 Reduced 1.5%
92,394 $14.7 Billion
Q4 2022

Aug 16, 2024

SELL
$138.31 - $165.87 $541,207 - $649,049
-3,913 Reduced 4.0%
93,804 $15.2 Billion
Q3 2022

Aug 16, 2024

SELL
$134.21 - $153.93 $46,034 - $52,797
-343 Reduced 0.35%
97,717 $13.1 Billion
Q2 2022

Aug 16, 2024

SELL
$137.62 - $174.96 $2.28 Million - $2.9 Million
-16,557 Reduced 14.45%
98,060 $15 Billion
Q1 2022

Aug 16, 2024

SELL
$131.98 - $163.75 $710,976 - $882,121
-5,387 Reduced 4.49%
114,617 $18.6 Billion
Q4 2021

Aug 16, 2024

SELL
$107.43 - $135.93 $445,512 - $563,701
-4,147 Reduced 3.34%
120,004 $16.2 Billion
Q3 2021

Aug 16, 2024

BUY
$106.4 - $120.78 $5.68 Million - $6.45 Million
53,428 Added 75.55%
124,151 $13.4 Billion
Q2 2021

Aug 16, 2024

BUY
$105.21 - $117.21 $19,884 - $22,152
189 Added 0.16%
119,933 $13.5 Billion
Q1 2021

Aug 16, 2024

BUY
$102.3 - $112.62 $97,901 - $107,777
957 Added 0.81%
119,744 $13 Billion
Q4 2020

Aug 16, 2024

SELL
$80.49 - $108.67 $224,164 - $302,645
-2,785 Reduced 2.29%
118,787 $12.7 Billion
Q3 2020

Aug 16, 2024

SELL
$85.91 - $100.83 $15,893 - $18,653
-185 Reduced 0.15%
121,572 $10.6 Billion
Q2 2020

Aug 16, 2024

SELL
$73.37 - $98.18 $407,496 - $545,291
-5,554 Reduced 4.36%
121,757 $12 Billion
Q1 2020

Aug 16, 2024

BUY
$64.5 - $97.79 $318,694 - $483,180
4,941 Added 4.04%
127,311 $9.7 Billion
Q4 2019

Aug 16, 2024

BUY
$72.13 - $90.25 $3.73 Million - $4.66 Million
51,647 Added 73.03%
122,370 $10.8 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $346B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.